Clinical trial
Evaluation of Adherence to Guidelines, and of the Risk to Benefit Ratio, in the Use of TNFα Antagonists in Pregnant Women With Inflammatory Bowel Diseases. Study on the French National PMSI Database
NCT03134508 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Adherence to Guidelines, and of the Risk to Benefit Ratio, in the Use of TNFα Antagonists in Pregnant Women With Inflammatory Bowel Diseases. Study on the French National PMSI Database
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- April 30, 2017
- Enrollment
- 8,726 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.